For more than 20 years, Golden Helix has focused on our mission to empower precision medicine around the world. We want you to know you have our commitment to continue providing you with the products and services you depend on during these unprecedented times.
Today, we have announced our latest efforts to help assist the clinical research community in this battle by offering significantly discounted 18-month software licenses for anyone researching or working on projects related to COVID-19.
These licenses will be available for any Golden Helix product or software bundle until May 15th, 2020. It is our goal to make our solutions as affordable as possible for those actively working in this space and ensure your organization has a dependable, robust analysis solution to carry you through the end of 2021 with no additional or unpredicted costs.
If you are researching or working on projects related to COVID-19, please contact our team before May 15th to determine which of our software solutions best fit your needs or visit our site at bit.ly/covid19ghi.
Please be safe and stay healthy.